|
|
|
|
Vol. 55, Issue 5, 787-794, May 1999
Department of Medicine, University of California, San Francisco, California
| |
Summary |
|---|
|
|
|---|
Sphingosine 1-phosphate (S1P) increases intracellular Ca2+ concentration in many cell types, but the signaling mechanism remains uncertain. The recent identification of three closely related seven-transmembrane domain receptors for S1P, termed Edg1, H218, and Edg3, support the extracellular ligand role of S1P and allowed examination of Ca2+ responses mediated specifically by each receptor subtype. To substantiate each subtype in S1P-induced Ca2+ responses and to study the transductional mechanisms, we applied the aequorin luminescence method and the fura-2 fluorescence method in two transfected mammalian cell systems. We showed that H218 and Edg3 were capable of mediating S1P-induced mobilization of intracellular Ca2+ when transiently transfected in human TAg-Jurkat T cells. Ca2+ responses mediated by Edg1 in TAg-Jurkat cells required coexpression of the Gqi5 chimeric G protein that links Gi-coupled receptors to Gq. When H218 and Edg3 were stably expressed in rat HTC4 hepatoma cells, S1P induced Ca2+ responses with nanomolar EC50 values. Edg3, but not H218, elicited a sustained influx of extracellular Ca2+. The coincident formation of inositol phosphates and the complete inhibition of Ca2+ responses by the phospholipase C inhibitor U73122 indicated that H218 and Edg3 mobilized Ca2+ through activation of phospholipase C. Partial inhibition of Ca2+ responses and inositol phosphates formation by pertussis toxin implied that H218 and Edg3 transduce phospholipase C activation and Ca2+ responses only partially through Gi proteins. Although these results did not dismiss that S1P may function as an intracellular second messenger in other settings, they definitively proved that S1P can mobilize Ca2+ as an extracellular ligand for G protein-coupled receptors.
| |
Introduction |
|---|
|
|
|---|
Several
types of lysosphingolipids regulate cell growth, differentiation, and
programmed cell death (Spiegel and Merrill, 1996
; Meyer zu Heringdorf
et al., 1997
). Sphingosine 1-phosphate (S1P) is a potent mediator of
mitogenesis (Zhang et al., 1991
; Goodemote et al., 1995
; Berger et al.,
1996
), cell motility and tumor cell invasiveness (Sadahira et al.,
1992
; Bornfeldt et al., 1995
), platelet activation (Yatomi et al.,
1997a
), and neurite retraction (Postma et al., 1996
). Cell signaling by
S1P evokes activation of mitogen-activated protein kinases (Wu et al.,
1995
), stimulation of Ik(Ach)
(Bünemann et al., 1996
; van Koppen et al., 1996
), and prominent
increases in intracellular Ca2+ concentration
([Ca2+]i) (Zhang et al.,
1991
; Durieux et al., 1993
; Chao et al., 1994
; Ghosh et al., 1994
;
Mattie et al., 1994
; Meyer zu Heringdorf et al., 1996
; Okajima et al.,
1996
; van Koppen et al., 1996
; Törnquist et al., 1997
; Yatomi et
al., 1997b
). Despite extensive observations in various cell types, the
mechanism by which S1P mobilizes intracellular Ca2+ is controversial. Some studies suggested
that S1P acts as an intracellular second messenger for
Ca2+ release directly from endoplasmic reticulum
(ER) through an inositol trisphosphate
(IP3)-independent mechanism (Ghosh et al., 1994
; Mattie et al., 1994
). However, the specific molecular target for S1P on
ER membranes, presumably a Ca2+ channel, has not
been identified.
Other studies demonstrated that exogenous S1P increases
[Ca2+]i via cell surface
G protein-coupled receptors (GPCRs) that activate phospholipase C (PLC)
(Bornfeldt et al., 1995
; Okajima et al., 1996
, 1997
; Im et al., 1997
;
Noh et al., 1998
). In support of an extracellular action of S1P, cDNAs
encoding three closely related seven-transmembrane-domain receptors,
termed Edg1, H218, and Edg3 (Edg, endothelial differentiation gene),
have recently been identified (An et al., 1997
; Lee et al., 1998
;
Zondag et al., 1998
). Two of these receptors, H218 and Edg3, mediated
S1P-induced serum response element (SRE)-driven transcription in Jurkat
cells and triggered Ca2+ efflux in
Xenopus oocytes (An et al., 1997
). The other receptor, Edg1,
induced cell-cell aggregation through enhanced cadherin expression,
inhibited adenylyl cyclase, and activated mitogen-activated protein
kinases via Gi protein (Lee et al., 1998
; Zondag
et al., 1998
). However, S1P-induced mobilization of intracellular
Ca2+ has yet to be attributed to these cloned
receptors expressed in mammalian cells and, therefore, the signaling
mechanism of S1P-induced Ca2+ responses remains uncertain.
In the present study, we expressed these cloned S1P receptors in two types of cultured mammalian cells and measured their abilities to transduce S1P-induced increases in [Ca2+]i by using two different methods. We demonstrated that H218 and Edg3, when transiently transfected in human TAg-Jurkat T cells or stably transfected in rat HTC4 hepatoma cells, were capable of mobilizing intracellular Ca2+. Furthermore, kinetic characteristics and biochemical signaling properties of H218- and Edg3-mediated Ca2+ mobilization were elucidated in the HTC4 stable transfectants.
| |
Materials and Methods |
|---|
|
|
|---|
Chemicals. S1P, sphingosine (SP), dihydro-sphingosine 1-phosphate (dHS1P), dihydro-sphingosine (dHSP), N,N-dimethyl-sphingosine (dMSP), psychosine (PS), and C6-ceramide (C6) were obtained from Biomol (Plymouth, PA). Sphingosylphosphorylcholine (SPC) was from Matreya, Inc. (Pleasant Gap, PA). 1-Oleoyl-2-hydroxy-sn-glycero-3-phosphate (LPA) was from Avanti Polar Lipid (Alabaster, AL). Fatty acid-free human serum albumin was purchased from Sigma (St. Louis, MO). SuperFect transfection reagent for transient transfection was from Qiagen (Hilden, Germany). LipofectAmine, OPTI-MEM medium, and Geneticin (G418 sulfate) were from Gibco-BRL (Gaithersburg, MD). Jurkat leukemic T cells containing the SV40 virus large T antigen (TAg-Jurkat) were obtained from Dr. J. Crabtree (Stanford University). Rat hepatoma HTC4 cells, cell culture media, and fetal bovine serum were from University of California-San Francisco Cell Culture Facilities. An apoaequorin expression construct targeted to cytoplasm (cytAEQ/pcDNA1), coelenterazine f, and fura-2/AM were from Molecular Probes (Eugene, OR). A G protein chimera, Gqi5, was kindly provided by Dr. B. Conklin (Gladstone Institute, University of California, San Francisco). U73122, U73343, SK&F96365, and pertussis toxin (PTX) were purchased from CalBiochem (La Jolla, CA). myo-[3H]Inositol with specific activity 80 Ci/mmol was from Amersham (Arlington Heights, IL). Dowex AG-1X8 resin (200-400 mesh) was obtained from Bio-Rad (Richmond, CA). The enzyme-linked cAMP assay kit was from PerSeptive Biosystems (Framingham, MA).
Transient Transfection of TAg-Jurkat Cells and Measurement of
cytoplasmic Ca2+ Using Aequorin Luminescence Method.
TAg-Jurkat T cells were cotransfected with the apoaequorin expression
plasmid (cytAEQ/pcDNA1) and receptor cDNA constructs, at a 1:5 ratio,
using SuperFect reagent. The sequences of expression plasmid for the
human Edg1, rat H218, and human Edg3 (Edg1/EF3, H218/EF3, and Edg3/EF3,
respectively) and the control vector pcDEF3 were previously reported
(An et al., 1997
). After 10 h of transfection incubation in
OPTI-MEM medium, cells were washed once with RPMI 1640 and incubated
with 5 µM coelenterazine f in RPMI 1640 for 2 h at
37°C. Cells were then washed twice and resuspended in PBS (containing
1 mM CaCl2) at 2 × 106 cells/ml. Light emission resulting from
Ca2+ binding to the apoaequorin-coelenterazine
complex was recorded by luminometry. To obtain kinetic data, aliquots
of 2 × 105 cells in 0.1 ml were transferred
into a 96-well plate that was placed in an EG&G Berthold microplate
luminometer (model LB96V; Berthold, Natick, MA). S1P and other
phospholipids dissolved in 0.1 ml of PBS containing 0.1 mg/ml of fatty
acid-free human serum albumin were added to the cells through an
automated injector. Light emission was recorded every 3 s for
60 s, beginning immediately after the injection. To obtain
integrated luminometric data, a Turner Designs 20/20 luminometer
(Mountain View, CA) was used to record light emission for 15 s,
beginning immediately after injection of S1P.
Stable Transfection of HTC4 Cells and Measurement of [Ca2+]i Using Fura-2 Fluorescence Method. Rat hepatoma HTC4 cells were transfected with receptor cDNA expression constructs H218/EF3, Edg3/EF3, or control vector pCDEF3 containing the geneticin-resistance gene using LipofectAmine. Selection for stable transfectants was begun 2 days after transfection, using 10% fetal bovine serum-supplemented DME medium containing 500 µg/ml of geneticin. Geneticin-resistant colonies were isolated after an additional 14 days and further cloned through limiting dilution. Levels of specific h218 or edg3 mRNA in each HTC4 cell transfectant were assessed by Northern blot analyses. Cell lines with comparable levels of h218 and edg3 mRNA were selected for further studies.
Quantification of [Ca2+]i and [cAMP]i in HTC4 cell transfectants expressing each subtype of S1P receptor was performed as previously described (An et al., 1994Measurement of [3H]Inositol Phosphate (IP)
Formation.
HTC4 cell transfectants expressing each subtype of S1P
receptor were incubated overnight in 6-well plates (1 × 106 cells/well). Cells were washed with
HEPES-buffered Hank's balanced saline solution, pH 7.4, and incubated
for 4 h with 10 µCi of myo-[3H]inositol. Cells were then
washed and incubated for 10 min with 10 mM LiCl and 1 mM
myo-inositol. Each incubation was stopped at the indicated
times after addition of 10 nM S1P with 5% trichloroacetic acid on ice.
Cell lysate supernatants were extracted three times with
water-saturated ether and neutralized with 0.2 M Tris buffer, pH 8.0. [3H]IPs were separated by Dowex AG-1X8 columns
and measured according to published procedures (Berridge et al., 1983
).
| |
Results |
|---|
|
|
|---|
Most cultured lines of mammalian cells express endogenous S1P
receptors, resulting in high background values in measurements of
Ca2+ mobilization by recombinant receptors using
the conventional fluorescence indicator method. Thus, we applied a
different method that uses the photoprotein apoaequorin from
coelenterate jellyfish Aequorea victoria. Apoaequorin forms
a bioluminescent aequorin complex with the luminophore coelenterazine.
Upon binding to Ca2+, this aequorin complex emits
luminescence, which can be detected by luminometry. The cDNA for
apoaequorin can be expressed in mammalian cells, allowing sensitive
detection of recombinant GPCR-mediated intracellular
Ca2+ mobilization (Button and Brownstein, 1993
;
Brini et al., 1995
). When transiently coexpressed with GPCRs in the
same subpopulation of cells, aequorin preferentially recorded
Ca2+ signals mediated by the transfected GPCRs.
We took advantage of this sensitive method to record
Ca2+ mobilization elicited by the cloned S1P
receptors with high signal/background ratios.
We chose TAg-Jurkat cells because of their high yields of expression
plasmids containing the SV40 replication origin and their relatively
low background responses. When used in the fura-2 fluorescence indicator assay, untransfected TAg-Jurkat cells responded to S1P with
small but significant increases in
[Ca2+]i (data not shown).
Transient transfection of H218, Edg3, or Edg1 did not further elevate
the Ca2+ responses (data not shown). However,
when the aequorin luminescence assay was used, the untransfected or
vector-transfected TAg-Jurkat cells showed only minimal responses to
S1P. Whereas, cells cotransfected with H218 or Edg3 showed significant
increases in light emission resulting from Ca2+
binding to aequorin (Fig. 1A). In H218
and Edg3 transfectants, light emission increased immediately after S1P
addition, peaked at 9 to 12 s, and then gradually returned to
baseline levels within 60 s. The magnitude of S1P-induced light
emission in Edg3-transfected cells was consistently greater than that
in H218-transfected cells (Fig. 1A). As controls, the
vector-transfected TAg-Jurkat T cells were stimulated with monoclonal
antibody C305 against the T cell receptor
chain (Fig. 1B). The time
course of light emission elicited by C305 showed a longer delay than
that evoked by S1P, which is consistent with the slow kinetics of
calcium mobilization through T cell receptor activation observed using
the fluorescence indicator method. Ionomycin at 1 µM generated a
large increase in light emission, which gradually returned to baseline
levels in 2 min (Fig. 1B).
|
In contrast, TAg-Jurkat cells transfected with Edg1 did not show
significant S1P-induced increases in luminescence (Fig.
2). To confirm expression of Edg1 in
these cells, we employed a chimeric Gq protein,
Gqi5, which has C-terminal five amino acids
changed from Gq
to Gi
residues allowing Gi-coupled receptors to
stimulate PLC (Conklin et al., 1993
). When cotransfected with Gqi5, Edg1 was able to significantly increase
aequorin luminescence in response to 100 nM S1P (Fig. 2). These results
suggested that Edg1 was indeed expressed in the TAg-Jurkat cells, and
that Edg1 has the potential to mediate Ca2+
responses if the Gi-PLC pathway is active in the
cells.
|
S1P increased
[Ca2+]i represented by
increases in aequorin luminescence in a concentration-dependent manner
(Fig. 3A). The mean EC50 values obtained from three independent
experiments were 8.0 ± 3.7 nM and 11 ± 5 nM for H218 and
Edg3, respectively. Two other lysosphingolipids, SPC and dHS1P, also
possess biological activities similar to S1P and were shown to interact
with H218 and Edg3 in SRE reporter gene transactivation (An et al.,
1997
). However, in the Ca2+ assays, the
EC50 of SPC and dHS1P were at least two orders of magnitude higher than that of S1P for Edg3 (Fig. 3B) and H218 transfectants (data not shown). The abilities of H218 and Edg3 to
recognize several other phospholipids were also examined (Fig. 4). At 1 µM, none of the other
sphingolipids and lysophospholipids tested, including SP, dHSP, dMSP,
PS, C6-Cer, or LPA induced significant responses in either H218 or
Edg3 transfectants (Fig. 4).
|
|
To further study the characteristics and mechanisms of
Ca2+ responses elicited by the recombinant H218
and Edg3 S1P receptors, we established cell lines stably expressing
H218 and Edg3. A rat hepatoma cell line, HTC4, was selected after
extensive search for a cell line possessing the lowest level of
endogenous S1P receptors detectable by Ca2+
response measurements and SRE reporter gene assays. We found that
untransfected and vector-transfected HTC4 cells had no detectable background increases in
[Ca2+]i in response to
S1P at concentration < 100 nM. In contrast, stably-transfected
cell lines expressing H218 or Edg3 showed large increases in
[Ca2+]i in response to
S1P. The effects are significant with 0.1 nM S1P and reached a maximum
at 100 nM S1P, with EC50 around 1 nM (Fig.
5A). SPC and dHS1P generated increases in
H218 or Edg3 transfected cell lines at concentrations higher than that
of S1P (Fig. 5B), consistent with the rank order of potencies obtained
from the aequorin luminescence assay (Fig. 3B). At 100 nM, other
structurally similar sphingolipids, such as SP, dHSP, dMSP, PS, and
C6-Cer, failed to generate any Ca2+ responses
(data not shown).
|
A difference in the kinetic curves for Ca2+ flux
with H218 and Edg3 was observed (Fig. 6).
This difference exists in all clones of each receptor examined despite
the broad range of magnitudes of
[Ca2+]i increases,
suggesting it is not the result of different levels of receptor
expression. For Edg3, the curve maintained a plateau after an initial
increase that lasted for >10 min. Whereas for H218, maximal increases
in [Ca2+]i returned to
the baseline levels within 2 min after the transient increase (Fig. 6).
To determine the sources of Ca2+ mobilized by
H218 and Edg3, changes in
[Ca2+]i were measured
after chelation of extracellular Ca2+. Incubation
with EGTA (final concentration, 3 mM) for 1 min before S1P addition
reduced the peak heights. More significantly, chelation of
extracellular Ca2+ eliminated the persistent
plateau in Edg3 (Fig. 6), suggesting that the sustained increase for
Edg3 was attributable to an influx of extracellular
Ca2+. Consistent with these results, pretreatment
of cells for 2 min with 20 µM SK&F96365, an inhibitor of
receptor-mediated Ca2+ entry (Merritt et al.,
1990
), did not eliminate the initial transient increase in H218 or
Edg3, but almost completely eliminated the plateau in Edg3 (Fig. 6).
Thus, the sustained plateau in Edg3 is due to receptor-activated
Ca2+ influx, and the immediate transient increase
in [Ca2+]i in both
receptors is mainly from the release of intracellular sources.
|
The Ca2+ release from intracellular sources was
further analyzed by employing thapsigargin (TG), an irreversible
inhibitor of the Ca2+-ATPase of ER, that depletes
intracellular Ca2+ pools (Takemura et al., 1989
).
The addition of 3 µM TG to EGTA-treated H218 and Edg3 transfectants
evoked an increase in
[Ca2+]i, which returned
to baseline levels in 3 min (Fig. 7).
This depletion of internal TG-sensitive Ca2+ pool
prevented any increase in
[Ca2+]i by subsequent
addition of S1P (Fig. 7). In contrast, when S1P was added first, TG
still caused a significant, albeit reduced increase in
[Ca2+]i (Fig. 7). These
data suggest that S1P-inducible Ca2+ pool is
entirely contained within the TG-sensitive internal
Ca2+ stores.
|
It has been well established that Ca2+
mobilization from internal stores elicited by GPCR activation is
mediated through IP3 generated by PLC
breakdown of phosphatidylinositol phosphates. Previously, it was shown
that S1P mobilized Ca2+ via G proteins that
activate phosphoinositide-specific PLC (Bornfeldt et al., 1995
; Okajima
et al., 1996
; Im et al., 1997
; Okajima et al., 1997
; Noh et al., 1998
).
To test whether recombinant H218 and Edg3 mobilize intracellular
Ca2+ through activation of PLC, we pretreated
cells with the U73122 PLC inhibitor before S1P addition. Pretreatment
with 3 µM U73122 for 2 min completely blocked S1P-induced increases
in [Ca2+]i in both H218
and Edg3 transfectants (Fig. 8). U73343,
an inactive compound used as a control for U73122, did not
significantly change the magnitude of Ca2+
responses (Fig. 8). To assess the involvement of PTX-sensitive G
proteins in S1P-induced Ca2+ mobilization by H218
and Edg3, cells were pretreated with 50 ng/ml PTX for 6 h. This
PTX treatment partially blocked S1P-induced Ca2+
responses in H218 and Edg3 transfectants by 31% ± 5% and 33% ± 8%, respectively (mean ± S.E., n = 6 experiments). As controls, the same PTX treatment almost completely
eliminated LPA-induced Ca2+ mobilization with
Edg2 LPA receptor transfectants of HTC4 cells (An et al., 1998
), and
completely blocked S1P suppression of adenylyl cyclase in Edg3
transfectants (An et al., unpublished observation).
|
We next measured the production of radiolabeled total IP and
IP3 after S1P stimulation. Treatment of H218 and
Edg3 transfectants with 10 nM S1P for 30 min significantly increased
cellular formation of total IP (Fig. 9A).
Treatment of H218 and Edg3 transfectants with 10 nM S1P for 1 and 5 min
also significantly increased IP3 production (Fig.
9B). The magnitudes of the increases in both total IP and
IP3 were greater in Edg3 than in H218
transfectants, parallel to the magnitudes of the increases in
[Ca2+]i (Fig. 5).
|
Sensitivity to inhibition by PTX in S1P-induced IP formation for H218
and Edg3 was also examined (Fig. 9C). PTX treatment partially blocked
total IP formation in H218 and Edg3 transfectants by 42% ± 6% and
49% ± 9%, respectively (mean ± S.E., n = 4 samples), but almost completely blocked it in Edg2 transfectants (91%
inhibition). As controls, the same PTX treatment did not significantly
change IP formation (Fig. 9C) and Ca2+ responses
(data not shown) induced by 10 µM ATP, which can mobilize intracellular Ca2+ predominantly through
Gq-coupled purinergic receptors (Parr et al.,
1994
). The coupling of Edg3 to Gi protein in HTC4
transfectants was further confirmed by the observation that S1P
suppressed [cAMP]i elevated by 10 µM
forskolin, and that this suppressive effect of S1P on adenylyl cyclase
was eliminated by PTX treatment (An et al., unpublished observation).
| |
Discussion |
|---|
|
|
|---|
Although the capacity of S1P to increase
[Ca2+]i in many cell
types has been well documented, its signal transductional mechanism remains obscure. The recent identification of Edg1, H218, and Edg3 as
receptors for S1P has provided the molecular basis for a GPCR-mediated
mechanism (An et al., 1997
; Lee et al., 1998
; Zondag et al., 1998
).
Expression of these receptors in mammalian cells has allowed
verification of the GPCR-mediated mechanism and characterization of the
signaling properties of S1P-elicited Ca2+
responses mediated by each specific subtype.
To overcome difficulties in characterizing cloned S1P receptors
resulting from background responses in many cultured mammalian cells,
we applied the aequorin luminescence method to monitor increases in
[Ca2+]i mediated by the
recombinant S1P receptors. H218 and Edg3 were able to mobilize
intracellular Ca2+ when expressed in Jurkat
cells. These Ca2+ responses were mediated
specifically by H218 and Edg3, because untransfected and
vector-transfected Jurkat cells did not respond to S1P. The
EC50 of S1P-induced Ca2+
responses for H218 and Edg3 is around 10 nM, which is similar to that
of native receptors in cultured cells (Okajima et al., 1996
; van Koppen
et al., 1996
; Törnquist et al., 1997
), and within the
concentration range obtained from biological fluids (Yatomi et al.,
1997a
). Edg3 transfectants consistently showed greater increases than
did H218 transfectants. Because we were unable to quantify the cell
surface expression levels of H218 and Edg3 proteins in these Jurkat
cell transfectants, it was not possible to compare the intrinsic
activities of these two receptors. Nevertheless, we were able to use
Ca2+ responses as functional readouts to test the
relative activities of several natural sphingolipids on H218 and Edg3.
We found that the specificities and rank orders of potency of ligands
were similar for H218 and Edg3. By far, S1P is the most potent natural
ligand of the phospholipids tested. When the aequorin luminescence
method was used, the same ligand specificities and rank orders of
potency were observed as with the fura-2 fluorescence method (Figs.
3-5). The high sensitivity and throughput of the aequorin method may be valuable in large-scale screenings for structure-activity
relationships of agonists or antagonists for specific subtypes of S1P receptors.
Several previous studies on Edg1-mediated Ca2+
response suggested that Edg1-mediated Ca2+
response is cell type-specific. In HEK293 and SF9 cells transfected with Edg1, S1P failed to elicit Ca2+ responses
(Van Brocklyn et al., 1998
; Zondag et al., 1998
), whereas in Chinese
hamster ovary (CHO) and human erythroleukemia (HEL) cells, Edg1 was
able to mediate Ca2+ response through
Gi/o (Okamoto et al., 1998
). In the current study
with TAg-Jurkat cells, Edg1 was capable of mobilizing
Ca2+ only when coexpressed with
Gqi5, which converts
Gi-coupled receptors to
Gq-activated effectors (Fig. 2). This result,
together with previous studies, suggests that Edg1 only couples to
Gi, which may or may not elicit a
Ca2+ response depending on the cellular
background. On the contrary, the ability of Edg3 or H218 alone to
generate a Ca2+ response suggests that they
couple to G proteins differently from Edg1 in TAg-Jurkat cells. Mostly
likely, Edg3 and H218 couple to Gq proteins to
mobilize Ca2+ in these cells. This notion is
supported by our finding that incubation with 50 ng/ml PTX for 6 h
did not significantly change the magnitude of 0.1 µM S1P-induced
increases in aequorin luminescence in Edg3- or H218-transfected
TAg-Jurkat cells (data not shown).
To further study the characteristics and signaling mechanisms of the Ca2+ responses by H218 and Edg3, we established HTC4 cell lines stably expressing H218 and Edg3. A difference in the kinetics of Ca2+ flux with H218 and Edg3 was observed. With Edg3, but not with H218, the initial release from TG-sensitive internal stores was followed by a sustained influx of extracellular Ca2+ (Fig. 6). It is noted that this sustained plateau in Edg3 was not observed in the aequorin luminescence assay (Fig. 1A). This difference between the two assays might be the result of either the differences between the two assays or cell type-specificity in Edg3-mediated Ca2+ flux.
Some studies have proposed an intracellular second messenger role of
S1P in Ca2+ mobilization that is independent of
IP3 generation. The major lines of evidence that
support this mode of S1P action include: first, high concentrations
(10-100 µM) of S1P released stored Ca2+
directly from the ER; second, heparin antagonism of
IP3 did not block this S1P-induced
Ca2+ release; and third, inhibitors of
sphingosine kinases, dMSP and dHSP, also blocked Fc
RI- and
muscarinic acetylcholine receptor-mediated Ca2+
responses (Ghosh et al., 1994
; Mattie et al., 1994
; Choi et al., 1996
;
Meyer zu Heringdorf et al., 1998
). To test whether H218- and
Edg3-mediated Ca2+ mobilization is achieved by
generation of S1P intracellularly, we examined whether dMSP, at
concentration that reportedly inhibited sphingosine kinases, would
alter S1P-induced Ca2+ responses. But, dMSP is
not a suitable agent to address this issue because dMSP alone at 10 µM induced a sustained elevation of
[Ca2+]i even in
vector-transfected HTC4 cells (data not shown). This observation
suggests that dMSP may directly alter intracellular Ca2+ homeostasis, a notion supported by a recent
finding that dMSP at 5 µM blocked Ca2+
release-activated Ca2+ current (store-operated
Ca2+ current) by 96% (Mathes et al., 1998
). The
effects of dMSP other than the inhibition of sphingosine kinases have
not been fully characterized, and caution should be taken when drawing
any conclusion about its effects on agonist-induced
Ca2+ responses.
In summary, we demonstrated that S1P mobilized Ca2+ through the defined cell surface GPCRs, H218 and Edg3, with nanomolar EC50 values. Edg1 has the potential to mediate Ca2+ responses through the Gi-PLC pathway given a proper cellular background. S1P-induced production of IP and elimination of Ca2+ responses by the PLC inhibitor U73122 strongly suggested that IP3 generated by PLC is responsible for H218 and Edg3-mediated Ca2+ mobilization. Partial inhibition of Ca2+ mobilization and IP formation by PTX implies that H218 and Edg3 transduce PLC-mediated increases in [Ca2+]i only partially through Gi proteins. Although these results did not rule out a possible role of S1P as an intracellular second messenger in some other settings, they did provide compelling molecular evidence for a GPCR-mediated mechanism of S1P-induced Ca2+ responses.
| |
Acknowledgments |
|---|
We are grateful to Yvonne Kong for technical assistance and Dr. Edward J. Goetzl for his suggestions regarding the manuscript.
| |
Footnotes |
|---|
Received September 23, 1998; Accepted February 3, 1999
This work was supported in part by a research grant from the American Heart Association (Grant-in-Aid 96007190 to S.A.).
Send reprint requests to: Dr. Songzhu An, Division of Immunology and Allergy, Department of Medicine, Box 0711, Room UB8, University of California, 533 Parnassus Ave., San Francisco, CA 94143-0711. E-mail: songzhu{at}itsa.ucsf.edu.
| |
Abbreviations |
|---|
S1P, sphingosine 1-phosphate; Edg, endothelial differentiation gene; LPA, lysophosphatidic acid; SP, sphingosine; dHS1P, dihydro-sphingosine 1-phosphate; dMSP, N,N-dimethyl-sphingosine; dHSP, dihydro-sphingosine; C6, C6-ceramide; PS, psychosine; G protein, guanine nucleotide-binding protein; GPCR, G protein-coupled receptor; [Ca2+]i, intracellular calcium concentration; PLC, phospholipase C; IP3, inositol 1,4,5-trisphosphate; PTX, pertussis toxin.
| |
References |
|---|
|
|
|---|
RI antigen receptor.
Nature
380:
634-636[Medline].This article has been cited by other articles:
![]() |
W. J. Valentine, J. I. Fells, D. H. Perygin, S. Mujahid, K. Yokoyama, Y. Fujiwara, R. Tsukahara, J. R. Van Brocklyn, A. L. Parrill, and G. Tigyi Subtype-specific Residues Involved in Ligand Activation of the Endothelial Differentiation Gene Family Lysophosphatidic Acid Receptors J. Biol. Chem., May 2, 2008; 283(18): 12175 - 12187. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Oz-Arslan, W. Ruscher, D. Myrtek, M. Ziemer, Y. Jin, B. B. Damaj, S. Sorichter, M. Idzko, J. Norgauer, and A. A. Maghazachi IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids J. Leukoc. Biol., August 1, 2006; 80(2): 287 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Kim, E. J. Jo, H.-Y. Lee, M. S. Cha, J. K. Min, C. H. Choi, Y. M. Lee, Y.-A. Choi, S.-H. Baek, S. H. Ryu, et al. Sphingosine 1-Phosphate in Amniotic Fluid Modulates Cyclooxygenase-2 Expression in Human Amnion-derived WISH Cells J. Biol. Chem., August 22, 2003; 278(34): 31731 - 31736. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Laychock, Y. Tian, and S. M. Sessanna Endothelial Differentiation Gene Receptors in Pancreatic Islets and INS-1 Cells Diabetes, August 1, 2003; 52(8): 1986 - 1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Shin, Y. P. Lee, T. S. Lee, H. D. Je, D. S. Kim, and U. D. Sohn The Signal Transduction of Endothelin-1-Induced Circular Smooth Muscle Cell Contraction in Cat Esophagus J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 924 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Coussin, R. H. Scott, A. Wise, and G. F. Nixon Comparison of Sphingosine 1-Phosphate-Induced Intracellular Signaling Pathways in Vascular Smooth Muscles: Differential Role in Vasoconstriction Circ. Res., July 26, 2002; 91(2): 151 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Fischer, N. Nusser, T. Virag, K. Yokoyama, D.-a. Wang, D. L. Baker, D. Bautista, A. L. Parrill, and G. Tigyi Short-Chain Phosphatidates Are Subtype-Selective Antagonists of Lysophosphatidic Acid Receptors Mol. Pharmacol., October 1, 2001; 60(4): 776 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. An, Y. Zheng, and T. Bleu Sphingosine 1-Phosphate-induced Cell Proliferation, Survival, and Related Signaling Events Mediated by G Protein-coupled Receptors Edg3 and Edg5 J. Biol. Chem., January 7, 2000; 275(1): 288 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Windh, M.-J. Lee, T. Hla, S. An, A. J. Barr, and D. R. Manning Differential Coupling of the Sphingosine 1-Phosphate Receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq, and G12 Families of Heterotrimeric G Proteins J. Biol. Chem., September 24, 1999; 274(39): 27351 - 27358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Young, M. D. Bootman, D. R. Channing, P. Lipp, P. R. Maycox, J. Meakin, R. A. J. Challiss, and S. R. Nahorski Lysophosphatidic Acid-induced Ca2+ Mobilization Requires Intracellular Sphingosine 1-Phosphate Production. POTENTIAL INVOLVEMENT OF ENDOGENOUS EDG-4 RECEPTORS J. Biol. Chem., December 1, 2000; 275(49): 38532 - 38539. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zhu, L. M. Baudhuin, G. Hong, F. S. Williams, K. L. Cristina, J. H. S. Kabarowski, O. N. Witte, and Y. Xu Sphingosylphosphorylcholine and Lysophosphatidylcholine Are Ligands for the G Protein-coupled Receptor GPR4 J. Biol. Chem., October 26, 2001; 276(44): 41325 - 41335. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Siehler, Y. Wang, X. Fan, R. T. Windh, and D. R. Manning Sphingosine 1-Phosphate Activates Nuclear Factor-kappa B through Edg Receptors. ACTIVATION THROUGH Edg-3 AND Edg-5, BUT NOT Edg-1, IN HUMAN EMBRYONIC KIDNEY 293 CELLS J. Biol. Chem., December 21, 2001; 276(52): 48733 - 48739. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ishii, B. Friedman, X. Ye, S. Kawamura, C. McGiffert, J. J. A. Contos, M. A. Kingsbury, G. Zhang, J. H. Brown, and J. Chun Selective Loss of Sphingosine 1-Phosphate Signaling with No Obvious Phenotypic Abnormality in Mice Lacking Its G Protein-coupled Receptor, LPB3/EDG-3 J. Biol. Chem., August 31, 2001; 276(36): 33697 - 33704. [Abstract] [Full Text] [PDF] |
||||
![]() |
|